Marsh 1 on a biopsy report with negative celiac blood tests: what the guidelines say

Short answer

A Marsh 1 result describes more lymphocytes than usual in the lining of the duodenum with normal villi7; the American College of Gastroenterology (ACG) says lymphocytic duodenosis without villous atrophy is not specific for celiac disease and that other causes should be considered1. The ACG also says a work-up to rule out celiac disease is indicated3, while a 2025 European guideline says that with negative celiac serology celiac disease is unlikely and other causes should be explored4. NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing5.

Published by Gluten Verdict · updated · 6 sources, each linked below

Reviewed by Mark Peter, Registered dietitian (RD), on

Folded paper and a parking stub on a car dashboard beside a coffee cup

Key points

  • Marsh 1 is a description of the biopsy, not a diagnosis. The ACG calls it “lymphocytic duodenosis” when the lymphocyte count reaches 25 or more per 100 epithelial cells and there is no villous atrophy2, 1.
  • Sources list many other causes, among them Helicobacter pylori infection, medicines such as NSAIDs, bacterial overgrowth, non-celiac gluten sensitivity and autoimmune disease15, 16.
  • The two guidelines differ in emphasis: the ACG says a work-up to rule out celiac disease is indicated3; the European guideline says stopping further analysis is acceptable when serology is negative22.
  • One pathology review says current data do not suggest histologic features that tell the causes apart19.
  • NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing5.

What Marsh 1 means on the report

A pathologist assigns a Modified Marsh Type to the biopsy findings. The Celiac Disease Foundation (CDF) says a Type of 3 indicates symptomatic celiac disease, but that Types 1 and 2 may also indicate celiac disease6.

Marsh 1 means the count of lymphocytes inside the gut lining (intraepithelial lymphocytes, or IELs) is raised while the crypts and villi look normal7. The ACG puts the threshold at 25 or more IELs per 100 epithelial cells and calls the finding lymphocytic duodenosis2. The CDF’s table uses a higher cut-off for the duodenum, more than 30 per 100 enterocytes7, so sources do not give one number. The European guideline calls the same finding lymphocytic duodenitis (Marsh-I stage)8.

How common is it?

  • ACG: lymphocytic infiltration is common in the general population, with a prevalence of 5.4%2.
  • Hammer and Greenson (a pathology review): the finding is seen in up to 3% of duodenal biopsies10.
  • European guideline: Marsh-I histology has been observed in 1.3%–6% of small-bowel biopsies9.

These figures come from different studies and populations and are not meant to be combined; they show only that the finding is not rare.

Why Marsh 1 with negative blood tests is not a contradiction

Marsh 1 is non-specific. Hammer and Greenson call it a finding “associated with a number of disease conditions” and say that historically between 9% and 40% of cases have been shown to represent celiac disease11. The ACG says most patients with lymphocytic duodenosis do not belong to the spectrum of celiac disease3.

For the case in this guide, the European guideline recommends that when Marsh-I is found with negative celiac serology, celiac disease is unlikely and other causes should be explored4. Its panel graded the certainty of evidence for that recommendation as low and the strength of the recommendation as strong14.

A negative blood test does not close the question in every case. The ACG says symptomatic patients whose pretest suspicion for celiac disease is high (above 5%) should have endoscopy with duodenal biopsy irrespective of serologic results, given the imperfect sensitivity of serology and the possibility of seronegative celiac disease12. For a person with IgA deficiency, the ACG says an IgG-based serology should be measured13.

Whether either of those applies to a particular report is a clinical judgement. This guide only reports what the sources say.

Causes that sources list besides celiac disease

Each row names a cause and the sources that list it. A source missing from a row did not name that cause in the passage we cite on Marsh 1 or lymphocytic duodenosis; it may mention it in another context, and that does not mean it rules it out.

Causes of Marsh 1 or lymphocytic duodenosis named in four sources
Cause or settingNamed by
Helicobacter pylori infectionACG15; European guideline16; Hammer and Greenson17; CDF18
Medicines, especially NSAIDs (nonsteroidal anti-inflammatory drugs)ACG15; European guideline (“drug-related reactions”)16; Hammer and Greenson17; CDF18
Small bowel bacterial overgrowthACG15; Hammer and Greenson17; CDF18
Non-celiac wheat or gluten sensitivityACG15; European guideline16
Wheat allergyEuropean guideline16
Autoimmune conditionsACG (“systemic autoimmune disorders”)15; European guideline16
Inflammatory bowel disease, including Crohn’s diseaseEuropean guideline16; Hammer and Greenson17; CDF18
Tropical sprueHammer and Greenson17
Immunoglobulin deficiencies (IgA deficiency, common variable immunodeficiency)European guideline16; CDF18
Infections other than H. pyloriEuropean guideline16; CDF (viral, parasitic, bacterial)18
Blood malignancies and irritable bowel syndromeEuropean guideline, as less frequent causes16
Dermatitis herpetiformis, family members of people with celiac disease, people already on a gluten-free dietCDF18

The list is long and the finding looks the same under the microscope: Hammer and Greenson say current data do not suggest histologic features that differentiate between the diseases associated with it19. The European guideline adds that determining the cause can be challenging and relies on clinical, serological and histopathological data together20. The CDF, summarising an article in the University of Chicago Celiac Disease Center’s newsletter, says it is critical that biopsies be reviewed by an expert gastroenterological pathologist so that all possible causes are considered21.

Our guides on non-celiac gluten sensitivity diagnosis and reading a biopsy report cover two of these topics in more depth.

What the guidelines say about next steps

The two guidelines we read are worded differently for this situation, and both are quoted here as written.

  • ACG: “workup to rule out CD is indicated” for lymphocytic duodenosis3.
  • European guideline: with Marsh-I and negative serology, the chance of progression to villous atrophy is negligible, and “the decision to stop further analysis is acceptable”22.

The passages we quote do not say how to choose between those two positions for a given person; that is a question for the treating gastroenterologist.

Tests the sources mention

  • HLA typing (DQ2 and DQ8 gene variants). The ACG says it may help in situations such as a mismatch between serology and histology, and that a negative result rules out celiac disease23. The European guideline says it should not be used routinely at first and is indicated when the diagnosis is uncertain24. NIDDK says that without these gene variants celiac disease is very unlikely, and that having them alone does not mean celiac disease25. See celiac genetic testing.
  • Antibody tests as part of the picture. The ACG’s serology approach measures TTG IgA on a regular gluten-containing diet, with a total IgA measurement if IgA deficiency has not been checked30.
  • A second opinion on the slides. The European guideline encourages pathologists to obtain one when assessing mild or borderline changes27, and notes that agreement between pathologists ranges from moderate to poor in borderline or mild lesions such as Marsh I and II28.
  • The number and sites of biopsies. The ACG recommends multiple duodenal biopsies, 1 or 2 from the bulb and at least 4 from the part beyond it29.

One ACG sentence is easy to misread. It says a gluten-free diet may be considered in symptomatic children and adults with lymphocytic duodenosis or Marsh II lesions who have elevated celiac-related antibodies, especially EMA26. It is conditioned on elevated antibodies, so it is not about the negative-blood-test case in this guide.

Why the gluten-free diet question waits

NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing because the diet can affect test results5. The European guideline says a gluten challenge is required if a patient suspected of having celiac disease has reduced or eliminated gluten before appropriate diagnostic evaluation31.

If you have already cut gluten, our gluten challenge guide describes what the guidelines say. When to change the diet is a decision for you and your clinician.

Questions to take back to the gastroenterologist

These are prompts, built from the sources above. They are not a checklist of tests anyone must have.

  • Does the report give the IEL count per 100 epithelial cells, and how many biopsies came from the bulb and from the rest of the duodenum? (The ACG recommends multiple biopsies29.)
  • Was total IgA measured along with TTG IgA, or an IgG-based test used?30, 13
  • Which of the other causes listed above does the team think fits my history: Helicobacter pylori, medicines such as NSAIDs, bacterial overgrowth, other conditions?15, 16
  • Is a second pathology opinion worthwhile on this slide?27
  • Would HLA typing help here, and what would each result change?23, 24
  • The ACG and the European guideline word the next step differently. Which approach are you following for me, and why?
  • What should I eat until the work-up is finished, and what would make you revisit the diagnosis?

Our questions to bring to a gastroenterologist guide has a longer list for the whole diagnostic process.

Marsh 1 has normal villi7. Our guides on seronegative celiac disease and villous atrophy from other causes cover separate situations. For the reverse pattern, the European guideline uses the term potential celiac disease for people with positive serology and the HLA-DQ2 or DQ8 gene variants whose biopsies show no architectural abnormalities (Marsh 0–I)32.

That term is defined by positive serology, so it does not describe a Marsh 1 report with negative serology32.

Questions people ask

Is Marsh 1 celiac disease?

Not by itself. The ACG says lymphocytic duodenosis without villous atrophy is not specific for celiac disease1, while the CDF says Types 1 and 2 may also indicate celiac disease6. The European guideline says determining the cause relies on clinical, serological and histopathological data together20.

Can Marsh 1 turn into villous atrophy?

The European guideline says that in people with Marsh-I and negative serology the chance of progression to full-blown villous atrophy is negligible22. That statement is limited to people with negative serology22.

Does a negative blood test rule out celiac disease with Marsh 1?

The European guideline says celiac disease is unlikely in that situation4. The ACG notes serology has imperfect sensitivity and that seronegative celiac disease is possible, which is why biopsy is advised when suspicion is high12.

More in Celiac diagnosis, testing and gluten sensitivity

Sources